ARTICLE | Clinical News
Topical ALA photodynamic therapy: Began Phase I/IIa trial
May 9, 1994 7:00 AM UTC
DUSA Pharmaceuticals Inc. (DUSA), Denville, N.J. Product: Topical ALA photodynamic therapy Indication: Plaque-stage psoriasis Status: Began Phase I/IIa trial in up to 60 patients, to establish optimal...